Healthtech Startups

Aktis Oncology discovers and develops targeted radiopharmaceuticals for treating solid tumors. The company serves oncology patients and healthcare providers in the cancer care sector.

7 investors

Alaffia offers Autodor, an AI platform that pre-processes prior authorization requests for health plan utilization management teams by extracting clinical data, applying policy-based logic, and generating human-reviewed case summaries. Its Auto Agents support prospective, concurrent, retrospective, emergency department, level of care, and specialty pharmacy reviews for health plans.

7 investors

Allergyamulet develops a portable food allergen and ingredient sensor to help people with food allergies safely identify potential allergens in food before consumption.

7 investors

Alumis is a clinical-stage biopharmaceutical company developing a late-stage portfolio of targeted therapies for immune-mediated diseases. It focuses on small-molecule drug discovery and development in immunology and inflammation.

7 investors

Andromeda Surgical develops an AI-guided surgical platform that provides GPS-like navigation and autonomous task capabilities to surgeons, starting with endourology procedures. The platform integrates with existing surgical tools to assist interventional surgeons in performing procedures with enhanced precision and reduced training requirements.

7 investors

AnswersNow provides virtual ABA therapy and parent training services for children with autism and their families. The company delivers evidence-based behavioral health treatment remotely with clinical oversight.

7 investors

Antiva Biosciences develops a topical therapeutic for women with high-risk HPV infection and pre-cancerous cervical lesions, utilizing antiviral prodrug chemistry. The company targets an unmet clinical need where no approved therapeutic options currently exist.

7 investors

Arcellx develops CAR T-cell therapies that are individually designed for each patient, using the immune system to target and attack cancer. The company focuses on cell therapy for cancer treatment.

7 investors

Artios develops DNA Damage Response (DDR)-based therapeutics for hard-to-treat solid tumors, including small-molecule inhibitors targeting ATR (alnodesertib) and DNA polymerase theta (ART6043). The company operates a proprietary DDR drug-development platform called DcoDeR and advances a pipeline of oncology product candidates through clinical trials.

7 investors

Arvinas is a biopharmaceutical company developing PROTAC protein degrader therapies, with a pipeline focused on oncology and neurology. It advances preclinical research into clinical-stage treatments for patients with limited or ineffective existing options.

7 investors

Asepha provides AI-powered automation solutions for pharmacies to automate routine administrative tasks like patient calls, prescription intake, and prior authorization workflows. The platform enables pharmacy staff to focus on clinical and patient care services while improving operational efficiency and revenue.

7 investors

Assured Allies provides insurance and health engagement solutions for older adults, partnering with financial institutions to deliver preventive care and protection services. The company serves financial institutions and their policyholders aged 60+.

7 investors

Athelas develops software tools for private practice healthcare providers to reduce administrative burden, improve operational efficiency, and enhance patient scheduling and navigation capabilities.

7 investors

Atropos Health develops a cloud-based platform that generates real-world evidence from electronic health records to inform clinical decision-making and healthcare research. The company enables healthcare institutions, clinicians, and life sciences organizations to rapidly conduct observational studies from patient data for personalized medicine and evidence-based practice.

7 investors

August Health builds software for senior living communities to support caregivers in delivering care. The platform includes EHR, eMAR, patient insights, billing, and care documentation tools.

7 investors

Axuall provides a workforce intelligence solution for healthcare staffing and operations, using clinician data to address needs in credentialing and workforce management. It serves healthcare organizations and leaders across the US.

7 investors

BardyDx develops the Carnation Ambulatory Monitor (CAM), a lightweight cardiac patch monitor designed for extended-wear ambulatory ECG monitoring that emphasizes P-wave signal clarity. The company serves healthcare professionals and patients requiring continuous arrhythmia detection and diagnosis.

7 investors

Béa provides an at-home fertility treatment and care service designed to help people conceive without relying on timed intercourse, offering expert support from the start of the conception journey. It serves individuals and couples trying to conceive, including those who have been attempting for six or more months.

7 investors

Quest Analytics provides cloud-based software and services for healthcare provider network management, including its Quest Enterprise Services (QES) platform for measuring, monitoring, and modeling network adequacy, compliance, performance, and provider data accuracy. It serves health payers and regulatory agencies across the United States, including CMS and state agencies.

7 investors

Bicycle Therapeutics develops precision-guided therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, designed to penetrate deep into tissues and target intractable solid tumor cancers. Beyond oncology, it collaborates with pharmaceutical partners and academic groups to apply the technology to other therapeutic areas including anti-infective, cardiovascular, ophthalmology, dementia, CNS, neuromuscular and respiratory conditions.

7 investors

bit.bio is a synthetic biology company that engineers human induced pluripotent stem cells into defined cell types for research, drug discovery, and cell therapy applications. The company markets cells and disease models through its ioCells brand for use in biomedical research and therapeutic development.

7 investors

Bloomlife provides a remote patient monitoring platform for high-risk patient populations, offering customizable clinical protocols and smart notifications that help care teams identify patients in need and address potential complications early. It is aimed at clinical care teams seeking greater oversight of at-risk patients.

7 investors

Branchlab offers an AI-driven platform for healthcare marketing that helps teams explore patient, HCP, and caregiver audiences without exposing Protected Health Information, then create, optimize, and activate those audiences across channels. It uses predictive modeling to target healthcare campaigns and measure real-world outcomes for marketers in the healthcare industry.

7 investors

BridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support. The company partners with academic institutions to advance early-stage research toward late-stage clinical trials.

7 investors